SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-082296
Filing Date
2021-06-17
Accepted
2021-06-17 06:30:48
Documents
12
Period of Report
2021-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120001d1_8k.htm   iXBRL 8-K 38043
  Complete submission text file 0001104659-21-082296.txt   210781

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrsn-20210611.xsd EX-101.SCH 3184
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrsn-20210611_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrsn-20210611_pre.xml EX-101.PRE 22709
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2120001d1_8k_htm.xml XML 3602
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38129 | Film No.: 211023338
SIC: 2834 Pharmaceutical Preparations